endometriosis
Conditions
Interventions
Endometrioma:Postoperative monitoring of drug treatment and recurrence
Deep infifltrating endometriosis:Postoperative monitoring of drug treatment and recurrence
Sponsors
Obstetrics and Gynecology Hospital of Fudan University
Eligibility
Sex/Gender
Female
Age
15 Years to 49 Years
Inclusion criteria
Inclusion criteria: 1. The collection will be held from November 2019 to September 2021 at the Obstetrics and Gynecology Hospital of Fudan University; 2. Aged 15 to 49 years old; 3. Complete basic information; 4. Complete in-patient medical history information, preoperative examination and surgical imaging data; 5. Complete clinical diagnosis and treatment process; 6. Surgery plus drug treatment; 7. The final postoperative diagnosis should be endometriosis and confirmed by histopathological examination; 8. Complete outpatient follow-up data for 2 years.
Exclusion criteria
Exclusion criteria: 1. Have Received endometriosis-related hormone therapy for more than 3 months before surgery; 2. Surgery is not performed by the fixed attending physician; 3. Pathological diagnosis does not support the evidence of endometriosis.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Recurrence of clinical symptoms;recurrence of lesion on physical examination;Recurrence of lesion on image;Recurrence time; | — |
Secondary
| Measure | Time frame |
|---|---|
| serum CA125;Pain relief;Fertility outcome; | — |
Countries
China
Contacts
Public ContactXiaofang Yi
Obstetrics and Gynecology Hospital of Fudan University
Outcome results
None listed